We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Stronger Presence in Healthcare IT for Philips After XIMIS Acquisition

By HospiMedica staff writers
Posted on 29 Aug 2007
Royal Philips Electronics (Amsterdam, The Netherlands) and XIMIS, Inc. More...
(El Paso, TX, USA) announced that Philips would acquire XIMIS, Inc., a provider of next-generation radiology information systems (RIS).

The transaction is expected to close in the third quarter of 2007. No financial details on the transaction were disclosed. XIMIS will be incorporated into the Healthcare Informatics business group of Philips' Medical Systems division.

XIMIS has experience in the healthcare industry, with emphasis in radiology information systems. XIMIS' major product is XIRIS (Extended Internet Radiology Information System), which is an industry-leading web-based RIS, scaling from community hospitals up to large, multiple facilities hospitals. XIRIS provides an international and multilingual system. Healthcare institutions across Europe and North and South America are customers of XIMIS.

"XIMIS is a company with very talented people and unique technology that will strengthen our position in Healthcare Informatics and will enable us to provide an integrated RIS-PACS [picture archiving communication system] solution,” said Oran Muduroglu, CEO of Philips Medical Systems' Healthcare Informatics business group.

XIRIS is designed to manage patient registration, scheduling, exam tracking, staff and resource management, and the generation of reports and statistical information, thereby reducing errors and streamlining the workflow at radiology facilities. Where XIRIS concentrates on workflow management at radiology facilities, Philips iSite PACS concentrates on image management and distribution. As such the XIRIS solution is complementary to the Philips iSite PACS and will further strengthen Philips' iSite PACS market position.

"Philips is strongly committed to the support of its current customer base and will work with them to take advantage of an integrated RIS-PACS solution,” Mr. Muduroglu added.

In commenting on the acquisition, Katitza Gerdau, founder and CEO of XIMIS, said, "Philips is the right home for XIRIS since it has a high quality organization with a global, international scope. This acquisition will provide XIRIS a foundation for the future. The RIS-PACS solution of iSite and XIRIS will be amongst the strongest on the market today and will offer a powerful solution to clinics, doctors, and to the patient. We are excited about this opportunity.”


Related Links:
Royal Philips Electronics
XIMIS

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Multi-Chamber Washer-Disinfector
WD 390
Pediatric Mask
Respire SOFT
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Artificial Intelligence

view channel
Image: Artificial intelligence (AI) standalone performance and reader performance with versus without AI assistance. (A) Receiver operating characteristics (ROC) curve for AI standalone performance in the US dataset (AUC 0.899, 95% CI 0.858 to 0.939). (B) ROC curve for AI standalone performance in the Korean dataset (AUC 0.963, 95% CI 0.946 to 0.975). (C) Pooled reader ROC without (AUC 0.718) versus with (AUC 0.852) AI assistance in the Korean dataset; P<0.001. AUC, area under the receiver operating characteristics curve. (Leonard Sunwoo et al., Journal of NeuroInterventional Surgery (2026). DOI: 10.1136/jnis-2026-025339)

AI Improves Non-Contrast CT Interpretation for Time-Sensitive Stroke Assessment

Acute ischemic stroke occurs when a blood vessel in the brain becomes blocked, requiring rapid diagnosis to enable timely reperfusion therapy. Emergency departments often use computed tomography angiography... Read more

Critical Care

view channel
Image Credit: Adobe Stock

Noninvasive Imaging Approach Aims to Detect Basal Cell Carcinoma Before It Becomes Visible

Basal cell carcinoma is the most common form of skin cancer and can damage nearby structures such as the nose or eyes when it develops on the face. Diagnosis typically depends on visible skin changes,... Read more

Surgical Techniques

view channel
Image: Associate Professor Menglin Chen studies how the light-sensitive nanoparticles affect living cells. The screen shows calcium being released inside a cell after nanoparticles taken up by the cell are exposed to blue light. Calcium plays an important role in cellular signaling, and the experiment helps the researchers understand how the nanoparticles can translate light into biological activity. (Photo courtesy of Aarhus University, Johanne Holm Jensen)

Light-Activated Nanoparticles May Offer New Approach to Retinal Prostheses

Retinitis pigmentosa is a degenerative retinal disorder in which photoreceptors progressively die, reducing visual signals to the brain while leaving surviving inner retinal circuits underused.... Read more

Point of Care

view channel
Image Credit: 123RF

Continuous Glucose Monitoring Identifies Cardiometabolic Risk in Adults Without Diabetes

Dysglycemia—abnormal blood glucose regulation—can fluctuate throughout the day and often escape conventional screening. Clinicians typically rely on fasting plasma glucose and hemoglobin A1c, which offer... Read more

Business

view channel
Image: LigaSure RAS Maryland, designed for the Valleylab FT10 platform on Hugo RAS, seals and cuts vessels, tissue, and lymphatics up to 7 mm in diameter (Photo courtesy of Medtronic)

Medtronic Receives FDA Clearance for Vessel-Sealing Instrument for Robotic Surgery

As robotic-assisted surgery expands across U.S. hospitals, teams increasingly seek energy instruments with the familiarity and performance of tools used in open and laparoscopic procedures.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.